Gastrointestinal Cancer News

Local administration of chimeric antigen receptor T cells via a fibrin-based gel effectively eliminated leftover cancer cells after incomplete surgical resection, study results published in Science Advances showed.

Healio | HemOnc Today is excited to announce the nominees for its second annual Disruptive Innovators Awards in oncology and hematology.

Circulating tumor DNA testing appeared to identify risk for recurrence among patients with stage II to stage IV colorectal cancer, according to study results published in Nature Medicine.

Private sector workers in the United States had a higher likelihood of undergoing colorectal or breast cancer screening if they lived in a jurisdiction with a paid-sick-leave mandate, results of a population-based study showed.

A machine learning model may aid the detection and classification of tertiary lymphoid structures associated with gastrointestinal cancers based on routine tissue slides, according to research in JAMA Network Open.

CMS has announced expanded coverage for specific colorectal cancer screening tests by lowering the minimum age to include individuals aged 45 years and older under Medicare Part B.

A greater percentage of colorectal cancer cases in the United States are being diagnosed at advanced stages, according to an American Cancer Society report.

Although colonoscopies performed later in the day correlated with a decreased adenoma detection rate, researchers reported that artificial intelligence systems may offset time-related decline in colonoscopy quality.

Direct oral anticoagulants showed greater efficacy and cost-effectiveness than low-molecular-weight heparin for treatment of cancer-associated thrombosis, according to data published in Annals of Internal Medicine.

Adjuvant chemotherapy appeared associated with a significant survival benefit among patients with pancreatic ductal adenocarcinoma who underwent multiagent neoadjuvant chemotherapy and resection, according to study results.